MEETINGS - Post-market Surveillance and Medical Device Vigilance for Medical Devices in Europe (UK) July 1998:
This article was originally published in Clinica
IBC Conferences will hold a meeting entitled Post-market Surveillance and Medical Device Vigilance for Medical Devices in Europe on July 2 in London. Discussion topics will focus on establishing effective post-market surveillance systems and how competent authorities are managing vigilance. For more information contact IBC in the UK. Tel: +44 171 453 5492. Fax: +44 171 636 6858.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.